Found: 9
Select item for more details and to access through your institution.
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1264723
- By:
- Publication type:
- Article
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1264723
- By:
- Publication type:
- Article
Hepatocyte Growth Factor Gene-Modified Adipose-Derived Mesenchymal Stem Cells Ameliorate Radiation Induced Liver Damage in a Rat Model.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114670
- By:
- Publication type:
- Article
Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 5, p. 837, doi. 10.1007/s00277-014-2278-7
- By:
- Publication type:
- Article
The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4249, doi. 10.3390/cancers13174249
- By:
- Publication type:
- Article
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 11, p. 3765, doi. 10.1002/cam4.3037
- By:
- Publication type:
- Article
Germline variants of DNA repair and immune genes in lymphoma from lymphoma‐cancer families.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 1, p. 93, doi. 10.1002/ijc.34892
- By:
- Publication type:
- Article
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03329-8
- By:
- Publication type:
- Article